Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Glipizide

29094-61-9C21H27N5O4S445.545 g/mol

An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number29094-61-9ChEBI ↗
Molecular formulaC21H27N5O4SChEBI ↗
Molar mass445.545 g/molChEBI ↗
Monoisotopic mass445.17838 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:5384ChEBI ↗

Cross-source molecular data

PubChem
Molar mass445.5 g/molPubChem ↗
Exact mass445.17837553 DaPubChem ↗
Computed XLogP1.9PubChem ↗
Topological polar surface area (Ų)139PubChem ↗
H-bond donors3PubChem ↗
H-bond acceptors6PubChem ↗
Rotatable bonds7PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
glipizide
N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide
ZJJXGWJIGJFDTL-UHFFFAOYSA-N
Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1
InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)

Names & synonyms

AldiabDigrinDipazideGlibeneseGlibetinGlicanGlidiabGlipidglipizidaglipizidumGluco-RiteGlucolip

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antiatherosclerotic agenthypoglycemic agentantineoplastic agentEC 2.7.1.33 (pantothenate kinase) inhibitorinsulin secretagogue

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00224444 mol

Uses 445.545 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 21 atoms
56.61%
N
Nitrogen · 5 atoms
15.72%
O
Oxygen · 4 atoms
14.36%
S
Sulfur · 1 atom
7.20%
H
Hydrogen · 27 atoms
6.11%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
DE2012138 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US3669966 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:5384

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 3478 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.